OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
5,720.00
+230.00 (4.19%)
At close: Jun 9, 2026
-6.99% (1Y)
| Market Cap | 102.35B -1.2% |
| Revenue (ttm) | 91.62B +11.8% |
| Net Income | 12.70B +39.8% |
| EPS | 796.92 +34.0% |
| Shares Out | 17.65M |
| PE Ratio | 7.28 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 118,235 |
| Open | 5,590.00 |
| Previous Close | 5,490.00 |
| Day's Range | 5,550.00 - 5,800.00 |
| 52-Week Range | 5,440.00 - 20,750.00 |
| Beta | -0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 23, 2026 |